Development of a New Patient Reported Outcome Measure (PROM) to Assess Patient's Emotional Wellbeing, and Perceptions of Total Knee Replacement Surgery for the Treatment of Knee Arthritis
- Conditions
- Complete Questionnaires Following TKR Surgery
- Registration Number
- NCT06585267
- Lead Sponsor
- Invibio Ltd
- Brief Summary
Development of a new Patient Reported Outcome Measure (PROM) to assess patient's emotional wellbeing, and perceptions of Total Knee Replacement surgery for the treatment of knee arthritis.
- Detailed Description
Patients will complete the final developed questionnaire for quantitative analysis only (involves no administration of any medicinal products or medical devices) and is considered a low-risk project.
Patients will also be asked to complete the already validated EQ-5D-5L and Oxford Knee Score questionnaires at the same time as the final developed questionnaire following their Total Knee Replacement surgery.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 150
- Patients aged 18 years of age or older.
- Patients who have undergone Total Knee Replacement surgery with a metal implant for the treatment of end-stage knee arthritis in the last 3 months.
- Patients who have only undergone one Total Knee Replacement surgery on the index knee.
- Patients who, in the opinion of the Investigator, are able to understand this project and co-operate with the requirements of participation.
- Patients who are able to give voluntary, written informed consent to participate in this project and from whom consent has been obtained.
- Patients, who in the opinion of the Investigator, exhibit evidence of any condition or co-morbidity that would compromise their participation in the project.
- Patients who are unable to understand and communicate fluently in English.
- Patients who have experienced a complication following Total Knee Replacement surgery requiring a further hospital admission or revision surgery to the index knee.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Validate final questionnaire From first post-op visit to 12month follow-up Validation of final questionnaire
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chapel Allerton Hospital
🇬🇧Leeds, United Kingdom